Woven EndoBridge装置治疗破裂颅内动脉瘤的安全性与有效性:系统综述与Meta分析
该系统综述与Meta分析纳入18项研究共487例患者496个破裂动脉瘤,评估Woven EndoBridge装置的安全性与有效性。结果显示晚期再出血率1.1%,治疗相关围手术期并发症率13.2%,总体临床并发症率3.2%,良好临床结局85%, adequate闭塞率87.3%,再治疗率5.1%。作者认为该装置在破裂动脉瘤管理中安全有效,但需进一步研究。
要点
- Woven EndoBridge治疗破裂动脉瘤的 adequate 闭塞率为87.3%(95%CI 82.1%-92.4%)。
- 晚期再出血率1.1%(95%CI 0.1%-2.1%),再治疗率5.1%(95%CI 3%-7.3%)。
- 治疗相关围手术期并发症率13.2%,总体临床并发症率3.2%。
核心结论
- 该Meta分析显示Woven EndoBridge装置在破裂动脉瘤管理中安全有效,但需进一步研究。
研究设计与样本
- 系统综述与Meta分析,检索Ovid Evidence-Based Medicine Reviews、EMBASE、MEDLINE、Scopus和Web of Science Core Collection从建库至2020年的所有研究,纳入18项研究共487例患者496个破裂动脉瘤,采用随机效应模型进行Meta分析。
诊断标准与关键数值
- 晚期再出血率1.1%(95%CI 0.1%-2.1%);治疗相关围手术期并发症率13.2%(95%CI 9.2%-17.2%);总体临床并发症率3.2%(95%CI 1.6%-4.7%);出血性并发症13例(2%;95%CI 0.8%-3.3%);血栓栓塞性并发症41例(6.8%;95%CI 4.6%-9%);良好临床结局85%;手术相关死亡率2.1%(95%CI 0.8%-3.3%);总体死亡率11.5%(95%CI 7%-16%);末次随访时adequate闭塞率87.3%(95%CI 82.1%-92.4%);再治疗率5.1%(95%CI 3%-7.3%)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 该Meta分析受选择偏倚和高异质性限制。
- 结论指出需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: The Woven EndoBridge device has been increasingly used to treat wide-neck aneurysms, particularly ruptured ones.
PURPOSE: Our aim was to investigate the safety and efficacy of the Woven EndoBridge device in the treatment of ruptured intracranial aneurysms.
DATA SOURCES: All studies evaluating the outcomes of Woven EndoBridge device use in the treatment of ruptured intracranial aneurysms from inception through 2020 were searched on Ovid Evidence-Based Medicine Reviews, EMBASE, MEDLINE, Scopus, and the Web of Science Core Collection.
STUDY SELECTION: Eighteen studies encompassing 487 patients with 496 ruptured aneurysms treated with the Woven EndoBridge device were included.
DATA ANALYSIS: We studied rates of rerupture and retreatment, angiographic outcomes at the last follow-up point, complications, and mortality rates. Data were collected on anticoagulation and antiplatelet use. Meta-analysis was performed using the random effects model.
DATA SYNTHESIS: The rate of late rebleeding was 1.1% (95% CI, 0.1%-2.1%). The treatment-related perioperative complication rate and the overall clinical complication rate were 13.2% (95% CI, 9.2%-17.2%) and 3.2% (95% CI, 1.6%-4.7%), respectively. Thirteen hemorrhagic (2%; 95% CI, 0.8%-3.3%) and 41 thromboembolic (6.8%; 95% CI, 4.6%-9%) complications occurred. Favorable clinical outcomes were achieved in 85% of patients. Procedure-related mortality and overall mortality rates were 2.1% (95% CI, 0.8%-3.3%) and 11.5% (95% CI, 7%-16%), respectively. At last follow-up, an adequate occlusion rate was 87.3% (95% CI, 82.1%-92.4%) and the retreatment rate was 5.1% (95% CI, 3%-7.3%).
LIMITATIONS: Our meta-analysis is limited by selection bias and high heterogeneity.
CONCLUSIONS: This meta-analysis demonstrated the safety and efficacy of the Woven EndoBridge device in the management of ruptured aneurysms, but further studies are needed.
引用
- Essibayi MA, Lanzino G, Brinjikji W, et al. Safety and Efficacy of the Woven EndoBridge Device for Treatment of Ruptured Intracranial Aneurysms: A Systematic Review and Meta-analysis. AJNR Am J Neuroradiol. 2021. PMID: 34117016. doi:10.3174/ajnr.A7174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。